§ Federal grant opportunity · HT942526SCIRPIIRA
DoW Spinal Cord Injury, Investigator-Initiated Research Award
Abigail Strock Contract Specialist is accepting applications for DoW Spinal Cord Injury, Investigator-Initiated Research Award. The deadline is November 12, 2026 and the published award range is Award amount not published.
Key facts
- Funder
- Abigail Strock Contract Specialist
- Application deadline
- November 12, 2026
- Award range
- Award amount not published
- Eligibility
- Eligibility criteria are published in the funding opportunity announcement.
- Geography
- United States
- Focus areas
- Research
- Opportunity number
- HT942526SCIRPIIRA
Program overview
Summary: The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Investigator-Initiated Research Award (IIRA) supports studies that have the potential to make an important contribution to spinal cord injury (SCI) research, patient care and/or quality of life. May focus on any phase of research from basic through translational science, though studies that focus solely on identifying intervention targets are discouraged. Distinctive Features: • This funding opportunity contains an Early-Career Partnership Option, which allows for two Principal Investigators (PIs). If this option is selected, at least one of the named PIs must be an early-career investigator. Only the initiating PI will submit a pre-application, but all PIs will need to submit full applications. The partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. If recommended for funding, each PI will be named on a separate award to the recipient organization(s). Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Abigail Strock Contract Specialist.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before November 12, 2026, allowing time for registration and validation.
Related grant opportunities
- ROSES 2025: C.2 Solar System Science
- NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
- NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
- NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.